Top Medical Device Companies & FDA Regulatory Pathways (2026)
How leading medical device companies use FDA regulatory pathways—510(k), De Novo, and PMA—to bring devices to market. Compare vetted 510(k) submission experts and get quotes for your program.
- FDA pathways used by top medtech firms
- 510(k), De Novo, and PMA in 2026
- Where to find expert support and quotes
FDA regulatory pathways: 510(k), De Novo, and PMA
Top medical device companies rely on three main FDA regulatory pathways to bring products to market in the U.S.: 510(k) premarket notification, De Novo, and PMA (Premarket Approval). The path depends on device class (I, II, or III), whether a predicate exists, and risk.
- 510(k): Most Class II devices. Substantial equivalence to a predicate. Typical path for many of the top medical device companies for mature product types. eSTAR is the standard format in 2026.
- De Novo: Novel, low-to-moderate risk devices with no predicate. Growing pathway for innovative medical device companies with first-of-a-kind technology.
- PMA: Class III and certain high-risk devices. Full clinical and manufacturing evidence. Used by top medical device companies for implants, life-supporting, and high-risk products.
In 2026, FDA continues to emphasize eSTAR for 510(k), cybersecurity and software documentation, and alignment with international standards. Leading firms invest in clear regulatory strategy and often work with vetted 510(k) and regulatory experts to speed time to market.
Top medical device companies and how they use FDA pathways
Large and mid-size medical device companies—from global players to focused innovators—routinely use FDA regulatory pathways to clear or approve devices. Many maintain in-house regulatory teams and still engage consultants for 510(k) submissions, De Novo strategy, or complex PMA support. What distinguishes top medical device companies in 2026 is a clear understanding of which pathway fits each product, robust quality systems, and timely engagement with FDA (e.g., Pre-Sub, Q-Sub) when needed.
Whether you are at a top medical device company or a growing medtech, comparing 510(k) submission service providers helps you get the right expertise—from classification and predicate selection to eSTAR drafting and submission support.
FDA regulatory pathways in 2026: what’s relevant
In 2026, FDA regulatory pathways continue to evolve. Key themes for medical device companies include:
- eSTAR as the default for 510(k) submissions
- Cybersecurity and software documentation (SAMD, FDA guidance)
- Quality Management System Regulation (QMSR) alignment
- Transparency and predicate selection for 510(k)
- Efficient use of Pre-Sub and Q-Sub for novel or complex devices
Top medical device companies stay ahead by mapping each product to the right FDA regulatory pathway early and by working with experienced consultants when in-house capacity is limited. You can explore 100+ vetted 510(k) submission experts and request quotes to match your device and timeline.
Get quotes from 510(k) and regulatory experts
Whether you need 510(k) submission support, De Novo strategy, or PMA preparation, Cruxi’s directory of 510(k) submission services lets you compare vetted consultants and firms and request quotes in minutes. Many serve top medical device companies as well as startups and mid-size manufacturers.
FAQ — Top medical device companies & FDA pathways 2026
What are the main FDA regulatory pathways for medical devices?
The main pathways are 510(k) (substantial equivalence for Class II), De Novo (novel low-to-moderate risk), and PMA (Class III and high-risk). Top medical device companies choose the pathway based on device class, predicate availability, and risk.
How do top medical device companies use the 510(k) pathway?
They use 510(k) for most Class II devices by demonstrating substantial equivalence to a predicate. In 2026, submissions are typically in eSTAR format. Many firms use in-house teams plus external 510(k) consultants for capacity or specialized expertise.
What’s different about FDA regulatory pathways in 2026?
eSTAR is standard for 510(k), cybersecurity/software expectations are well established, and QMSR alignment is in effect. Top medical device companies plan for these when mapping products to FDA regulatory pathways.
Where can I get quotes from 510(k) experts?
You can compare and get quotes from vetted 510(k) submission experts in the 510(k) submission services directory. Filter by expertise, review profiles, and request quotes for your device and timeline.
Sources and references
This page is for informational purposes only. Cruxi is a marketplace; we match you with independent consultants and firms. We do not provide legal or regulatory advice. Privacy Policy · Terms of Service.